0 Commentaires
0 Parts
554 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Reels
-
Blogs
-
Offres
-
Emplois
-
Connectez-vous pour aimer, partager et commenter!
-
Liquid Biopsy Integration and AI: Projecting the US Biopsy Devices Market forecastThe US Biopsy Devices Market forecast is optimistic, though it faces an interesting technological divergence driven by the emergence of liquid biopsy Technologies. While liquid biopsy provides valuable, non-invasive genetic Market Data, it is not expected to replace tissue biopsy Product Types, but rather complement them, creating a combined diagnostic Standard...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Lung Cancer Liquid Biopsy Market – Industry Trends and Forecast to 2030Regional Overview of Executive Summary Lung Cancer Liquid Biopsy Market by Size and Share CAGR Value Data Bridge Market Research analyses that the lung cancer liquid biopsy market which was USD 0.30 billion in 2022, is expected to reach USD 1.38 billion by 2030, at a CAGR of 21% during the forecast period 2023 to 2030. The market report also contains the drivers and restraints...0 Commentaires 0 Parts 793 Vue 0 Aperçu
-
Biopsy Devices Market: How Are Liquid Biopsy Devices Creating a New Diagnostic Market?Liquid biopsy — the analysis of circulating tumor DNA, circulating tumor cells, exosomes, and other cancer-derived materials in blood samples providing cancer detection, characterization, and monitoring without tissue biopsy — represents the most commercially disruptive innovation in the biopsy devices market, with the Biopsy Devices Market reflecting liquid biopsy as a rapidly...0 Commentaires 0 Parts 939 Vue 0 Aperçu
-
Emerging Innovations In The Liquid Tumor Biopsy MarketThe Liquid Tumor Biopsy Market growth continues to accelerate as precision oncology increasingly shifts toward non-invasive, real-time monitoring of cancer progression and treatment response. With rising global cancer incidence and growing demand for alternatives to traditional tissue biopsies—which are often invasive, painful, and geographically constrained—the adoption of...0 Commentaires 0 Parts 80 Vue 0 Aperçu
-
Exosome Diagnostics and Therapeutics Market Drivers in United States: Rising Demand for Liquid Biopsy and Precision MedicineThe Exosome Diagnostics and Therapeutics Market is gaining strong momentum as a next-generation segment within biotechnology and precision medicine, driven by its expanding role in early disease detection, biomarker discovery, and targeted drug delivery systems. Exosomes, which are nanosized extracellular vesicles involved in intercellular communication, are increasingly recognized for...0 Commentaires 0 Parts 959 Vue 0 Aperçu
-
Exosome Therapeutics Market: How Are Exosome Diagnostics Advancing Liquid Biopsy?Engineered exosomes — the genetically or chemically modified exosomes with enhanced targeting, improved cargo loading, or augmented therapeutic properties beyond naturally derived exosomes — represent the next technological evolution addressing the limitations of native exosome therapeutics, with the Exosome Therapeutics Market reflecting engineered exosomes as the primary...0 Commentaires 0 Parts 790 Vue 0 Aperçu
-
Extracellular-Vesicles-Based-Liquid-Biopsy-Market Size, Share, Trends & Forecast Report 2026–2032Global Demand Outlook for Executive Summary Extracellular Vesicles Based Liquid Biopsy Market Size and Share The global extracellular vesicles based liquid biopsy market size was valued at USD 115.09 Million in 2024 and is expected to reach USD 539.41 Million by 2032, at a CAGR of 21.3% during the forecast period In order to make smart decisions about...0 Commentaires 0 Parts 672 Vue 0 Aperçu
-
Global Liquid Biopsy MarketThe latest report titled “Global Liquid Biopsy Market” published by Emergen Research is projected to register a significant growth rate during the forecast period from 2024 to 2034. The Market Intelligence Report provides a complete overview of the Liquid Biopsy market along with details on the competitive landscape and profiles of the key players operating in this business. Our...0 Commentaires 0 Parts 676 Vue 0 Aperçu
-
Liquid Biopsy Market Transforming Cancer Diagnostics and Precision MedicineThe liquid biopsy market is rapidly redefining how cancer is detected, monitored, and treated. Unlike traditional tissue biopsies, liquid biopsy relies on a simple blood sample to identify tumor-derived components such as circulating tumor DNA (ctDNA), RNA, and exosomes. This non-invasive approach is emerging as a cornerstone of precision medicine, enabling clinicians to make...0 Commentaires 0 Parts 767 Vue 0 Aperçu
-
Liquid Biopsy Market Trends Transforming the Future of Precision Cancer DiagnosticsThe global Liquid Biopsy Market is poised for significant growth, projected to expand from USD 15.9 billion in 2025 to USD 61.1 billion by 2033, registering a CAGR of 19.1% during the forecast period. The market is witnessing rapid momentum due to the increasing adoption of non-invasive diagnostic technologies, growing prevalence of cancer worldwide, and...0 Commentaires 0 Parts 23 Vue 0 Aperçu
-
Liquid Tumor Biopsy Market Advancements Supporting Early Disease DetectionThe Liquid Tumor Biopsy Market growth continues to accelerate as precision oncology increasingly shifts toward non-invasive, real-time monitoring of cancer progression and treatment response. With rising global cancer incidence and growing demand for alternatives to traditional tissue biopsies—which are often invasive, painful, and geographically constrained—the adoption of...0 Commentaires 0 Parts 94 Vue 0 Aperçu
-
How Liquid Biopsy Is Revolutionizing Early Cancer DetectionThe Liquid Biopsy Market has experienced remarkable growth in recent years, driven by increasing demand for non-invasive cancer diagnostics, advancing sensitivity of cell-free DNA detection technologies, and growing recognition of liquid biopsy as essential for precision oncology and early cancer detection. These innovative diagnostic platforms analyze circulating biomarkers including...0 Commentaires 0 Parts 160 Vue 0 Aperçu
-
How Liquid Biopsy Is Transforming Cancer Diagnosis Across ChinaThe China Liquid Biopsy Market has experienced remarkable growth in recent years, driven by increasing cancer incidence, growing demand for non-invasive molecular diagnostics, and expanding government support for precision medicine and innovative medical device development. These advanced diagnostic platforms analyze circulating tumor DNA, circulating tumor cells, and exosomes from blood...0 Commentaires 0 Parts 144 Vue 0 Aperçu
-
The Future of Non-Invasive Oncology: Breast Cancer Liquid Biopsy Market Size, Share, and Trajectory (2026–2033)According to the latest report published by Data Bridge Market Research, the Breast Cancer Liquid Biopsy Market The global ophthalmic operational microscope market was valued at USD 421.30 million in 2024 and is expected to reach USD 2,220.14 million by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 23.09%, primarily driven by the rising...0 Commentaires 0 Parts 246 Vue 0 Aperçu
-
The Future of Non-Invasive Oncology: Breast Cancer Liquid Biopsy Market Size, Share, and Trajectory (2026–2033)According to the latest report published by Data Bridge Market Research, the Breast Cancer Liquid Biopsy Market The global ophthalmic operational microscope market was valued at USD 421.30 million in 2024 and is expected to reach USD 2,220.14 million by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 23.09%, primarily driven by the rising...0 Commentaires 0 Parts 232 Vue 0 Aperçu
Plus de résultats